| When mutants gain new powers: news from the mutant p53 field R Brosh, V Rotter Nature reviews cancer 9 (10), 701-713, 2009 | 1378 | 2009 |
| Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis N Rivlin, R Brosh, M Oren, V Rotter Genes & cancer 2 (4), 466-474, 2011 | 1234 | 2011 |
| Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues G Landan, NM Cohen, Z Mukamel, A Bar, A Molchadsky, R Brosh, ... Nature genetics 44 (11), 1207-1214, 2012 | 309 | 2012 |
| p53 is balancing development, differentiation and de-differentiation to assure cancer prevention A Molchadsky, N Rivlin, R Brosh, V Rotter, R Sarig Carcinogenesis 31 (9), 1501-1508, 2010 | 205 | 2010 |
| p53-dependent down-regulation of telomerase is mediated by p21waf1 I Shats, M Milyavsky, X Tang, P Stambolsky, N Erez, R Brosh, I Kogan, ... Journal of Biological Chemistry 279 (49), 50976-50985, 2004 | 201 | 2004 |
| p53‐repressed miRNAs are involved with E2F in a feed‐forward loop promoting proliferation R Brosh, R Shalgi, A Liran, G Landan, K Korotayev, GH Nguyen, E Enerly, ... Molecular systems biology 4 (1), 229, 2008 | 185 | 2008 |
| Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells R Sarig, N Rivlin, R Brosh, C Bornstein, I Kamer, O Ezra, A Molchadsky, ... Journal of Experimental Medicine 207 (10), 2127-2140, 2010 | 176 | 2010 |
| TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model O Leshem, S Madar, I Kogan-Sakin, I Kamer, I Goldstein, R Brosh, ... PloS one 6 (7), e21650, 2011 | 149 | 2011 |
| Modulated expression of WFDC1 during carcinogenesis and cellular senescence S Madar, R Brosh, Y Buganim, O Ezra, I Goldstein, H Solomon, I Kogan, ... Carcinogenesis 30 (1), 20-27, 2009 | 105 | 2009 |
| Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature H Solomon, Y Buganim, I Kogan-Sakin, L Pomeraniec, Y Assia, S Madar, ... Journal of cell science 125 (13), 3144-3152, 2012 | 101 | 2012 |
| p53 Regulates the Ras circuit to inhibit the expression of a cancer-related gene signature by various molecular pathways Y Buganim, H Solomon, Y Rais, D Kistner, I Nachmany, M Brait, S Madar, ... Cancer research 70 (6), 2274-2284, 2010 | 92 | 2010 |
| Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1 I Kogan-Sakin, M Cohen, N Paland, S Madar, H Solomon, A Molchadsky, ... Carcinogenesis 30 (4), 698-705, 2009 | 91 | 2009 |
| Wide-scale analysis of human functional transcription factor binding reveals a strong bias towards the transcription start site Y Tabach, R Brosh, Y Buganim, A Reiner, O Zuk, A Yitzhaky, M Koudritsky, ... PloS one 2 (8), e807, 2007 | 88 | 2007 |
| The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation Y Tabach, M Milyavsky, I Shats, R Brosh, O Zuk, A Yitzhaky, R Mantovani, ... Molecular systems biology 1 (1), 2005.0022, 2005 | 88 | 2005 |
| Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect M Milyavsky, I Shats, A Cholostoy, R Brosh, Y Buganim, L Weisz, I Kogan, ... Cancer Cell 11 (2), 133-146, 2007 | 84 | 2007 |
| A critical role of PRDM14 in human primordial germ cell fate revealed by inducible degrons A Sybirna, WWC Tang, M Pierson Smela, S Dietmann, WH Gruhn, ... Nature communications 11 (1), 1282, 2020 | 83 | 2020 |
| A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype Y Buganim, I Goldstein, D Lipson, M Milyavsky, S Polak-Charcon, ... PloS one 5 (3), e9657, 2010 | 76 | 2010 |
| Structural Basis of Restoring Sequence-Specific DNA Binding and Transactivation to Mutant p53 by Suppressor Mutations☆ ZS O Suad, H Rozenberg, R Brosh, Y Diskin-Posner, N Kessler, L.J.W Shimon, F ... J. Mol. Biol 385, 249-265, 2009 | 76 | 2009 |
| Coupling transcriptional and post-transcriptional miRNA regulation in the control of cell fate R Shalgi, R Brosh, M Oren, Y Pilpel, V Rotter Aging (Albany NY) 1 (9), 762, 2009 | 74 | 2009 |
| p53 counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition R Brosh, Y Assia-Alroy, A Molchadsky, C Bornstein, E Dekel, S Madar, ... Cell Death & Differentiation 20 (2), 312-320, 2013 | 64 | 2013 |
Jef D. BoekeNYU Langone Health在 nyulangone.org 的电子邮件经过验证
